Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03BLG
|
|||
| Former ID |
DNCL001697
|
|||
| Drug Name |
AGS-009
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Systemic lupus erythematosus [ICD-11: 4A40.0; ICD-9: 710] | Phase 1 | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00960362) An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE). U.S. National Institutes of Health. | |||
| REF 2 | Emerging Therapies for Systemic Lupus Erythematosus - Focus on Targeting Interferon-alpha. Clin Immunol. 2012 June; 143(3): 210-221. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.